UPDATE: Cyberonics Announces Response To Submission For Reconsideration Of Coverage Of VNS Therapy® in Treatment-Resistant Depression
May 28, 2013 at 17:30 PM EDT
Cyberonics, Inc. (NASDAQ: CYBX ) today announced the receipt of a letter from the Centers of Medicare and Medicaid Services (CMS) declining the company's request to reconsider the 2007 National Coverage Determination for the treatment-resistant depression indication. "Cyberonics is very disappointed in the position taken by CMS that the new evidence accumulated over the
